Free Trial

Synthomer (LON:SYNT) Shares Up 9.5% - What's Next?

Synthomer logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Shares rose 9.5% intraday to GBX 32.68 on heavy volume (2,446,689 shares, ~40% above average) during Friday trading.
  • Analysts maintain an overall "Hold" consensus; Deutsche Bank cut its target from GBX 96 to GBX 62, while the average price target stands at GBX 90.50.
  • Fundamentals show a small market cap (£53.42M), a negative P/E (-0.64) and high debt-to-equity (97.65), with the 50‑day SMA (GBX 33.75) below the 200‑day SMA (GBX 51.03), signalling weak profitability and a longer-term downtrend.
  • Five stocks we like better than Synthomer.

Shares of Synthomer plc (LON:SYNT - Get Free Report) traded up 9.5% during mid-day trading on Friday . The company traded as high as GBX 33 and last traded at GBX 32.68. 2,446,689 shares were traded during trading, an increase of 40% from the average session volume of 1,752,670 shares. The stock had previously closed at GBX 29.85.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft decreased their target price on Synthomer from GBX 96 to GBX 62 and set a "hold" rating on the stock in a report on Monday, February 2nd. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Synthomer presently has an average rating of "Hold" and an average price target of GBX 90.50.

Check Out Our Latest Analysis on Synthomer

Synthomer Price Performance

The company has a quick ratio of 0.97, a current ratio of 1.64 and a debt-to-equity ratio of 97.65. The firm has a market cap of £53.42 million, a PE ratio of -0.64, a P/E/G ratio of -0.17 and a beta of 1.86. The firm's fifty day simple moving average is GBX 33.75 and its two-hundred day simple moving average is GBX 51.03.

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines